Clinical trial
A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled 3-Part Trial of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Subjects With Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease
NCT02534844 is registered in ClinicalTrials.gov with Mandos LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled 3-Part Trial of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Subjects With Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease
- Lead sponsor
- Mandos LLC
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- March 28, 2018
- Enrollment
- 56 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.